Lv11
20 积分 2021-07-21 加入
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
11小时前
待确认
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
1个月前
已完结
Peptidylarginine deiminases 4 as a promising target in drug discovery
2个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Anti-Tumor Efficacy in Solid Tumors
3个月前
已完结
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
3个月前
已完结
The manufacturing considerations of bispecific antibodies
4个月前
已完结
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
4个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
5个月前
已完结
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity
6个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
7个月前
已完结
皖公网安备34019202002308
